![Tim Wilson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tim Wilson
Chief Executive Officer at Epsilogen Ltd.
Tim Wilson active positions
Companies | Position | Start | End |
---|---|---|---|
Epsilogen Ltd.
![]() Epsilogen Ltd. Pharmaceuticals: MajorHealth Technology Epsilogen Ltd. engages in the development of immunoglobulin E (IgE) antibodies to treat cancer. The firm offers IGEG platform technology based on combining the power of IgE and Immunoglobulin G (IgG) antibody molecules. The company was founded by Sophia Karagiannis and James Spicer and is headquartered in London, United Kingdom. | Director/Board Member | 31/03/2017 | - |
Chief Executive Officer | 31/03/2017 | - |
Career history of Tim Wilson
Former positions of Tim Wilson
Companies | Position | Start | End |
---|---|---|---|
Pacific Growth Equities, Inc.
![]() Pacific Growth Equities, Inc. Investment Banks/BrokersFinance Pacific Growth Equities, Inc. is a research-driven investment bank located headquartered in San Francisco with an additional office in Boston. The firm specializes in technology-based emerging growth companies. They offer investment banking and brokerage services including public equity offerings, private equity offerings and mergers and acquisitions. Pacific Growth focuses on the life sciences, technology, healthcare and consumer growth companies. | Analyst-Equity | 31/12/2005 | 27/02/2009 |
UBS Securities LLC
![]() UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Analyst-Equity | - | - |
Hambrecht & Quist LLC | Analyst-Equity | - | - |
Bear Stearns International Ltd. | Analyst-Equity | - | - |
Training of Tim Wilson
University of Cambridge | Doctorate Degree |
Imperial College London | Undergraduate Degree |
Statistics
International
United Kingdom | 5 |
United States | 4 |
Operational
Analyst-Equity | 4 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectoral
Finance | 5 |
Consumer Services | 3 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 5 |
---|---|
Pacific Growth Equities, Inc.
![]() Pacific Growth Equities, Inc. Investment Banks/BrokersFinance Pacific Growth Equities, Inc. is a research-driven investment bank located headquartered in San Francisco with an additional office in Boston. The firm specializes in technology-based emerging growth companies. They offer investment banking and brokerage services including public equity offerings, private equity offerings and mergers and acquisitions. Pacific Growth focuses on the life sciences, technology, healthcare and consumer growth companies. | Finance |
Bear Stearns International Ltd. | Finance |
Hambrecht & Quist LLC | Finance |
UBS Securities LLC
![]() UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Finance |
Epsilogen Ltd.
![]() Epsilogen Ltd. Pharmaceuticals: MajorHealth Technology Epsilogen Ltd. engages in the development of immunoglobulin E (IgE) antibodies to treat cancer. The firm offers IGEG platform technology based on combining the power of IgE and Immunoglobulin G (IgG) antibody molecules. The company was founded by Sophia Karagiannis and James Spicer and is headquartered in London, United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Tim Wilson
- Experience